The nonprofit People for the Ethical Treatment of Animals (PETA) has filed shareholder resolutions with four companies, including General Electric Co., calling for detailed new procedures that would reduce and replace animal use in research and development.
In addition to submitting a shareholder resolution with GE, PETA has filed resolutions with Pfizer, Charles River Laboratories and Merck. Among the complaints lodged with the four companies, PETA claims that GE in the past has failed to give proper pain relief to rabbits that were used in experiments.
“Shareholders have a right to know what goes on behind the closed doors of their companies’ laboratories,” said Kathy Guillermo, senior vice president of laboratory investigations of PETA, in a Dec. 19 statement.
